Skip to main content
OpenTrials

Clinical trial condition

Diabetes Mellitus, Type 2

Explore clinical trials studying Diabetes Mellitus, Type 2. Study availability and eligibility vary by location and protocol.

2,679 public trials 158 recruiting studies
Refine in advanced search Browse all conditions

Diabetes Mellitus, Type 2 trial results

Completed

Study Assessing Saxagliptin Treatment In Type 2 Diabetic Subjects Who Are Not Controlled With Metformin Alone

NCT00121667

Conditions
Diabetes Mellitus, Diabetes Mellitus, Type 2, Endocrine System Diseases, +3 more
Locations
  • Local Institution Anniston, Alabama, United States
  • Local Institution Birmingham, Alabama, United States
  • Local Institution Calera, Alabama, United States
  • Local Institution Haleyville, Alabama, United States
View all 152 locations
View Trial Details
Completed

Study to Compare the Efficacy and Safety of Administration of the Fix Dose Combination of Linagliptin Plus Metformin in Drug naïve Type 2 Patients

NCT01708902

Conditions
Diabetes Mellitus, Diabetes Mellitus, Type 2, Endocrine System Diseases, +3 more
Locations
  • 1288.18.86001 Boehringer Ingelheim Investigational Site Beijing, China
  • 1288.18.86002 Boehringer Ingelheim Investigational Site Beijing, China
  • 1288.18.86003 Boehringer Ingelheim Investigational Site Beijing, China
  • 1288.18.86004 Boehringer Ingelheim Investigational Site Beijing, China
View all 56 locations
View Trial Details
Completed

A Study of LY2189265 Compared to Sitagliptin in Participants With Type 2 Diabetes Mellitus on Metformin

NCT00734474

Conditions
Diabetes Mellitus, Diabetes Mellitus, Type 2, Endocrine System Diseases, +3 more
Locations
  • For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Peoria, Arizona, United States
  • For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Phoenix, Arizona, United States
  • For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Tucson, Arizona, United States
  • For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Fresno, California, United States
View all 99 locations
View Trial Details
Completed

GSK189075, GW869682 Or Placebo In Type 2 Diabetic Patients

NCT00291356

Conditions
Diabetes Mellitus, Diabetes Mellitus, Type 2, Endocrine System Diseases, +4 more
Locations
  • GSK Investigational Site Chula Vista, California, United States
  • GSK Investigational Site Neuss, North Rhine-Westphalia, Germany
  • GSK Investigational Site Berlin, State of Berlin, Germany
View Trial Details
Completed

Effect of AC2993 Compared With Insulin Glargine in Patients With Type 2 Diabetes Also Using Combination Therapy With Sulfonylurea and Metformin

NCT00082381

Conditions
Diabetes Mellitus, Diabetes Mellitus, Type 2, Endocrine System Diseases, +3 more
Locations
  • Radiant Research-San Diego San Diego, California, United States
  • Dorothy L. and James E. Frank Diabetes Research Institute San Mateo, California, United States
  • Internal Medicine Associates Department of Research Fort Myers, Florida, United States
  • Jacksonville Center for Clinical Research Jacksonville, Florida, United States
View all 91 locations
View Trial Details

Related conditions